"Hypoglycemic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances which lower blood glucose levels.
| Descriptor ID |
D007004
|
| MeSH Number(s) |
D27.505.696.422
|
| Concept/Terms |
Hypoglycemic Agents- Hypoglycemic Agents
- Agents, Hypoglycemic
- Antihyperglycemics
- Antihyperglycemic Agents
- Agents, Antihyperglycemic
- Hypoglycemic Drugs
- Drugs, Hypoglycemic
- Hypoglycemics
Hypoglycemic Effect- Hypoglycemic Effect
- Effect, Hypoglycemic
- Hypoglycemic Effects
- Effects, Hypoglycemic
Antidiabetics- Antidiabetics
- Antidiabetic Drugs
- Drugs, Antidiabetic
- Antidiabetic Agents
- Agents, Antidiabetic
|
Below are MeSH descriptors whose meaning is more general than "Hypoglycemic Agents".
Below are MeSH descriptors whose meaning is more specific than "Hypoglycemic Agents".
This graph shows the total number of publications written about "Hypoglycemic Agents" by people in this website by year, and whether "Hypoglycemic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 3 | 2 | 5 |
| 2005 | 4 | 2 | 6 |
| 2006 | 2 | 1 | 3 |
| 2007 | 5 | 0 | 5 |
| 2008 | 3 | 2 | 5 |
| 2009 | 3 | 4 | 7 |
| 2010 | 8 | 7 | 15 |
| 2011 | 4 | 1 | 5 |
| 2012 | 6 | 1 | 7 |
| 2013 | 9 | 5 | 14 |
| 2014 | 8 | 7 | 15 |
| 2015 | 11 | 5 | 16 |
| 2016 | 5 | 2 | 7 |
| 2017 | 7 | 4 | 11 |
| 2018 | 2 | 2 | 4 |
| 2019 | 4 | 1 | 5 |
| 2020 | 2 | 2 | 4 |
| 2021 | 1 | 3 | 4 |
| 2022 | 2 | 3 | 5 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 1 | 2 |
| 2025 | 7 | 1 | 8 |
| 2026 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypoglycemic Agents" by people in Profiles.
-
Glycemic Control and Utilization Risk With the Conversion of Glimepiride to Glipizide in Adults 64?Years and Older at an Integrated Health Care System. J Am Geriatr Soc. 2026 Jul; 74(7):1971-1978.
-
Medication adherence and persistence of newly initiated medications in older adults with diabetes. J Am Pharm Assoc (2003). 2026 May-Jun; 66(3):103075.
-
Pharmacist Intervention for Safer Prescribing in Patients With Type 2 Diabetes at High Risk: A Randomized Clinical Trial. JAMA Netw Open. 2026 02 02; 9(2):e2559946.
-
Comparative safety of glucose-lowering medications on depression in adults with type 2 diabetes. Diabetes Obes Metab. 2026 03; 28(3):2215-2226.
-
Early glycemic control and subsequent risk of incident dementia among new metformin users. Am J Med. 2026 Mar; 139(3):321-332.
-
Comparative Weight Change With Initiation and Adherence to Common Medications for Type 2 Diabetes. Obesity (Silver Spring). 2025 Nov; 33(11):2205-2213.
-
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study. Diabetes Care. 2025 Oct 01; 48(10):1737-1743.
-
Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes. JAMA Netw Open. 2025 10 01; 8(10):e2536100.
-
GLP-1RA comparative effectiveness against dementia onset relative to other antidiabetic medications in a large, multi-site cohort of patients with type 2 diabetes. Alzheimers Dement. 2025 Sep; 21(9):e70621.
-
Diabetes Deprescribing in Older Adults: A Randomized Clinical Trial. JAMA Intern Med. 2025 Aug 01; 185(8):926-935.